DENTSPLY SIRONA (XRAY) Updates FY 2018 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) updated its FY 2018 earnings guidance on Thursday. The company provided earnings per share guidance of $2.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.08. DENTSPLY SIRONA also updated its FY18 guidance to $2.00-2.15 EPS.

Several research analysts have recently weighed in on the stock. HC Wainwright set a $40.00 price target on shares of DENTSPLY SIRONA and gave the stock a hold rating in a research note on Friday, August 31st. ValuEngine upgraded shares of DENTSPLY SIRONA from a strong sell rating to a sell rating in a research note on Wednesday, October 24th. Robert W. Baird cut shares of DENTSPLY SIRONA from an outperform rating to a neutral rating and lowered their target price for the company from $56.00 to $38.00 in a research note on Tuesday, August 7th. Stifel Nicolaus lowered their target price on shares of DENTSPLY SIRONA from $57.00 to $46.00 and set a buy rating on the stock in a research note on Wednesday, August 8th. Finally, Morgan Stanley cut shares of DENTSPLY SIRONA from an overweight rating to an equal weight rating and lowered their target price for the company from $54.00 to $40.00 in a research note on Wednesday, August 8th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company. DENTSPLY SIRONA has a consensus rating of Hold and a consensus price target of $51.50.

Shares of XRAY traded down $0.74 during trading hours on Friday, reaching $36.06. 8,501,655 shares of the stock traded hands, compared to its average volume of 2,934,481. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.10 and a current ratio of 1.69. DENTSPLY SIRONA has a 52-week low of $33.93 and a 52-week high of $68.98. The stock has a market cap of $8.12 billion, a price-to-earnings ratio of 14.21, a price-to-earnings-growth ratio of 2.12 and a beta of 1.15.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.08). The firm had revenue of $928.40 million for the quarter, compared to analysts’ expectations of $951.58 million. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. The firm’s quarterly revenue was down 8.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.70 EPS. On average, equities research analysts predict that DENTSPLY SIRONA will post 2.07 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “DENTSPLY SIRONA (XRAY) Updates FY 2018 Earnings Guidance” was published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at


DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Read More: Should You Consider an Index Fund?

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with's FREE daily email newsletter.

Leave a Reply